• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Akorn, Inc.

NASDAQ:AKRX

$13.70 $0.11 (0.81%)

REAL-TIME: Last trade at

Akorn initiated with a Buy at Auriga

Akorn price target raised to $16 from $14 at Piper Jaffray

3 Stocks Hit 52-Week Highs

Akorn, Inc. (AKRX) Tops Q1 EPS by 2c; Reaffirms Outlook

Akorn reaffirms previously issued 2012 outlook

Akorn sees FY12 CapEx $30M-$40M

Akorn sees FY12 EPS 44c-46c, consensus 52c

Akorn reports Q1 EPS 13c, consensus 11c

Akorn, Inc. Announces First Quarter 2012 Earnings Release and Conference Call Information

ViroPharma Shares Plunge As Vancocin Goes Generic

Akorn rises 6.3%

Akorn jumps on generic Vancocin approval, resistance is at $13.09

Akorn announces approval and launch of generic Vancocin

Akorn Announces the Approval and Launch of Generic Vancocin®

Akorn management to meet with Needham

Brinson Patrick Securities Initiates Research Coverage of Akorn, Inc.

Brinson Patrick Securities Initiates Research Coverage of Akorn, Inc.

Small Caps: Bigger Run Ahead?

Akorn reverses lower from open, support at $11.70, its 50-day MA

Akorn gaps up in pre-market trade, resistance at $13.09, a recent pivot high

Akorn sees FY12 adjusted EPS 44c-46c, consensus 56c

Akorn reports Q4 adjusted EPS 11c, consensus 9c

Akorn, Inc. (AKRX) Tops Q4 EPS by 2c

Akorn Reports 2011 Fourth Quarter and Year-End Financial Results

Akorn Announces the Appointment of Dr. Adrienne Graves, Ph.D. to its Board of Directors

Akorn, Inc. (AKRX) Announces Completion of Kilitch Drugs India Limited Acquisition

Akorn completes acquisition of certain assets of Kilitch Drugs in India

2012 Economic Outlook - Report Highlights Akorn, Inc. and Ironwood Pharmaceuticals, Inc.

Akorn price target raised to $15 from $13 at Deutsche Bank

Akorn management to meet with Deutsche Bank

3 Stocks Hitting 52-Week Highs: Akorn, Sunoco Logistics, Cincinnati Financial

A Forward Look, The Year Ahead - Featured Research on AMAG Pharmaceuticals, Inc. and Akorn, Inc.

S&P Indices Announces Changes to U.S. Indices

Akorn to be added to S&P 600; Blue Coat Systems deleted as of 2/13 close

Akorn, Inc. - Momentum

Akorn, Inc. Announces Fourth Quarter 2011 Earnings Release and Conference Call Information

Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceuticals Holdings Inc., Southwest Airlines Co. and UnitedHealth Group Inc.

Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceuticals Holdings Inc., Southwest Airlines Co. and UnitedHealth Group Inc. - Press Releases

Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceuticals Holdings Inc., Southwest Airlines Co. and UnitedHealth Group Inc. - Press Releases

Akorn guidance for 2012 leaves room for upside, says Piper Jaffray

See More Articles...